Publications

Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece

Published on: Vaccines
Authors: George Gourzoulidis , Charalampos Tzanetakos , Argyro Solakidi , Eleftherios Markatis, Marios Detsis , Diana Mendes , Myrto Barmpouni, ,

Abstract Background/Objectives: To evaluate the health benefits, costs, and cost-effectiveness of vaccination with bivalent respiratory syncytial virus stabilized prefusion F vaccine (RSVpreF) for the prevention of lower respiratory tract disease caused by respiratory...

Read More

Setting Treatment Selection Criteria for Breast Cancer From a Clinician Perspective: Is It a Matter of Cost?

Published on: Value in Health
Authors: George Gourzoulidis, Athanasios Balasopoulos, Efi Chaviara, Petros Savourdos, Charalampos Tzanetakos,

Abstract: OBJECTIVES: Several systemic therapeutic options are available for breast cancer(BC) and oncologists assess the appropriate regimen for each patient based on disease and treatment characteristics through major health budget constraints.The aim of the study...

Read More

Beyond the Hospital Walls: Hospital at Home Programs for Cancer Patients Worldwide and the Road to Implementation in Greece

Published on: Value in Health
Authors: Emmanouela Braoudaki, Vasiliki Gkioka, Olga Balaoura, Charalampos Tzanetakos, George Gourzoulidis, ,

Abstract: OBJECTIVES: To examine the hospital at home programs for cancer patients globally, and determine the services, target population, model of care, and program characteristics. Additionally, we assessed their applicability and identified barriers and...

Read More

Cost Analysis of Managing Brain Metastases in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer in Greece

Published on: Value in Health
Authors: Oresteia Zisimopoulou, Andrianos Liavas, Charalampos Tzanetakos, Geroge Gouroulidis, ,

Abstract: OBJECTIVES: Patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (aNSCLC) are at high risk of developing brain metastases (BM), thus entailing significant clinical and economic burden. The aim of this study was to...

Read More

Cost-Effectiveness Analysis of Upadacitinib in Patients with Moderately to Severely Active Ulcerative Colitis in Greece

Published on: Value in Health
Authors: Charalampos Tzanetakos, Marina Psarra, Ilias Kotsis, George Gourzoulidis, ,

Abstract: OBJECTIVES: To evaluate the cost-effectiveness of upadacitinib in patients with moderately to severely active ulcerative colitis (UC), who have had an inadequate response, lost response or were intolerant to either conventional therapy (bio-naive) or a...

Read More

Archive per Year